Erratum: Genetic variation in the carbonyl reductase 3 gene confers risk of type 2 diabetes and insulin resistance: A potential regulator of adipogenesis (Journal of Molecular Medicine DOI: 10.1007/s00109-012-0898-8);Genetic variation in the carbonyl reductase 3 gene confers risk of type 2 diabetes and insulin resistance: A potential regulator of adipogenesis

Journal of Molecular Medicine

Volumn 90, Issue 7, 2012, Pages 847-858

  Chang, Yi Cheng ^a,b   Liu, Pi Hua ^c   Tsai, Yun Chih ^a   Chiu, Yen Feng ^d   Shih, Shyang Rong ^a   Ho, Low Tone ^e,f   Lee, Wen Jane ^g   Lu, Chieh Hua ^h   Quertermous, Thomas ⁱ   Curb, J David ^j   Lee, Wei Jei ^k   Lee, Po Chu ^a   He, You Han ^a   Yeh, Jih I ^l   Hwang, Juey Jen ^a   Tsai, Shu Huei ^a   Chuang, Lee Ming ^a,m  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b GENOMICS RESEARCH CENTER   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^e TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^f NATIONAL YANG MING UNIVERSITY   (Taiwan)

^g TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^h TRI SERVICE GENERAL HOSPITAL   (Taiwan)

ⁱ STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j UNIVERSITY OF HAWAII   (United States)

^k MIN SHENG GENERAL HOSPITAL   (Taiwan)

^l BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^m NATIONAL TAIWAN UNIVERSITY   (Taiwan)

more..

Author keywords

Adipogenesis; CBR3; Insulin resistance; Prostaglandin; Single nucleotide polymorphism; Type 2 diabetes

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROSTAGLANDIN; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA;

ADIPOGENESIS; ADULT; AGED; ARTICLE; CBR3 GENE; CELL DIFFERENTIATION; CELL STRAIN 3T3; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROSTAGLANDIN METABOLISM; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84865147062     PISSN: 09462716     EISSN: 14321440     Source Type: Journal    
DOI: 10.1007/s00109-012-0921-0     Document Type: Erratum

References (34)

1. Funk CD (2001) Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294:1871-1875 (Pubitemid 33101574)
2. Forman BM, Tontonoz P, Chen J, Brun RP, Spiegelman BM, Evans RM (1995) 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 83:803-812 (Pubitemid 3006324)
3. Chou WL, Chuang LM, Chou CC, Wang AH, Lawson JA, FitzGerald GA, Chang ZF (2007) Identification of a novel prostaglandin reductase reveals the involvement of prostaglandin E2 catabolism in regulation of peroxisome proliferator- activated receptor gamma activation. J Biol Chem 282:18162-18172 (Pubitemid 47100215)
4. Vegiopoulos A, Müller-Decker K, Strzoda D, Schmitt I, Chichelnitskiy E, Ostertag A, Berriel Diaz M, Rozman J, Hrabe de Angelis M, Nüsing RM et al (2010) Cyclooxygenase-2 controls energy homeostasis in mice by de novo recruitment of brown adipocytes. Science 328:1158-1161
5. Jaworski K, Ahmadian M, Duncan RE, Sarkadi-Nagy E, Varady KA, Hellerstein MK, Lee HY, Samuel VT, Shulman GI, Kim KH et al (2009) AdPLA ablation increases lipolysis and prevents obesity induced by high-fat feeding or leptin deficiency. Nat Med 15:159-168
6. Richelsen B, Pedersen SB (1987) Antilipolytic effect of prostaglandin E2 in perfused rat adipocytes. Endocrinology 121:1221-1226 (Pubitemid 17155864)
7. Ragolia L, Palaia T, Hall CE, Maesaka JK, Eguchi N, Urade Y (2005) Accelerated glucose intolerance, nephropathy, and atherosclerosis in prostaglandin D2 synthase knock-out mice. J Biol Chem 280:29946-29955 (Pubitemid 41177073)
8. Fujitani Y, Aritake K, Kanaoka Y, Goto T, Takahashi N, Fujimori K, Kawada T (2010) Pronounced adipogenesis and increased insulin sensitivity caused by overproduction of prostaglandin D2 in vivo. FEBS J 277:1410-1419
9. Sears DD, Miles PD, Chapman J, Ofrecio JM, Almazan F, Thapar D, Miller YI (2009) 12/15-Lipoxygenase is required for the early onset of high fat diet-induced adipose tissue inflammation and insulin resistance in mice. PLoS One 4:e7250
10. González-Ortiz M, Martínez-Abundis E, Balcázar- Muñoz BR, Robles-Cervantes JA (2010) Inhibition of cyclooxygenase-1 or -2 on insulin sensitivity in healthy subjects. Horm Metab Res 33:250-253
11. Sears DD, Miles PD, Chapman J, Ofrecio JM, Almazan F, Thapar D, Miller YI (2008) Selective COX2 inhibition improves whole body and muscular insulin resistance in fructose-fed rats. Eur J Clin Invest 38:812-819
12. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20:1183-1197
13. Chang YC, Chang TJ, Jiang YD, Kuo SS, Lee KC, Chiu KC, Chuang LM (2007) Association study of the genetic polymorphisms of the transcription factor7-like 2 (TCF7L2) gene and type 2 diabetes in the Chinese population. Diabetes 56:2631-2637 (Pubitemid 47523272)
14. Chang CH, Shau WY, Jiang YD, Li HY, Chang TJ, Sheu WH-H, Kwok CF, Ho LT, Chuang LM (2010) Type 2 diabetes prevalence and incidence among adults in Taiwan during 1999-2004: a national health insurance data set study. Diabet Med 27:636-643
15. American Diabetes Association (2004) Standards of medical care in diabetes. Diabetes Care 27(Suppl 1):S15-S35
16. Chang TJ, Liu PH, Liang YC, Chang YC, Jiang YD, LI HY, Lo MT, Chen HS, Chuang LM (2011) Genetic predisposition and nongenetic risk factors of thiazolidinedione-related leg edema in patients with type 2 diabetes. Pharmagonent Genomics 21:829-36
17. Lin JW, Chang YC, Li HY, Chien YF, Wu MY, Hsieh YC, Chen YJ, Hwang JJ, Chuang LM (2009) Cross-sectional validation of diabetes risk scores for predicting diabetes, metabolic syndrome, and chronic kidney disease in Taiwanese. Diabetes Care 32:2294-2296
18. Ranade K, Wu KD, Risch N, Olivier M, Pei D, Hsiao CF, Chuang LM, Ho LT, Jorgenson E, Pesich R et al (2001) Genetic variation in aldosterone synthase predicts plasma glucose levels. Proc Natl Acad Sci USA 98:13219-13224 (Pubitemid 33051343)
19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 8:412-419 (Pubitemid 15018832)
20. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265 (Pubitemid 40202029)
21. The International HapMap Consortium (2005) A haplotype map of the human genome. Nature 437:1299-1320
22. Johnson AD, O'Donnell CJ (2009) An open access database of genome-wide association results. BMC Med Genet 10:6
23. Horvath S, Xu X, Laird NM (2001) The family based association test method: strategies for studying general genotype-phenotype associations. Eur J Hum Genet 9:301-306 (Pubitemid 32366699)
24. Purcell S, Cherny SS, Sham PC (2003) Genetic Power Calculator: design of linkage and association mapping studies of complex traits. Bioinfromatics 19:149-150 (Pubitemid 36150192)
25. Scott LJ, Mohlke KL, Bonnycastle LL, Willer CJ, Li Y, Duren WL, Erdos MR, Stringham HM, Chines PS, Jackson AU et al (2007) A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316:1341-1345 (Pubitemid 46871655)
26. Nitz I, Fisher E, Grallert H, Li Y, Gieger C, Rubin D, Boeing H, Spranger J, Lindner I, Schreiber S et al (2007) Association of prostaglandin E synthase 2 (PTGES2) Arg298His polymorphism with type 2 diabetes in two German study populations. J Clin Endocrinol Metab 92:3183-3188 (Pubitemid 47236389)
27. Lindner I, Helwig U, Rubin D, Fischer A, Marten B, Schreiber S, Döring F, Schrezenmeir J (2007) Prostaglandin E synthase 2 (PTGES2) Arg298His polymorphism and parameters of the metabolic syndrome. Mol Nutr Food Res 51:1447-1451
28. Konheim YL, Wolford JK (2003) Association of a promoter variant in the inducible cyclooxygenase-2 gene (PTGS2) with type 2 diabetes mellitus in Pima India. Hum Genet 113:377-381 (Pubitemid 37254241)
29. Pilka ES, Niesen FH, Lee WH, El-Hawari Y, Dunford JE, Kochan G, Wsol V, Martin HJ, Maser E, Oppermann U (2009) Structural basis for substrate specificity in human monomeric carbonyl reductases. PLoS One 4:e7113
30. Forrest GL, Gonzalez B (2000) Carbonyl reductase. Chem Biol Interact 129:21-40 (Pubitemid 32061052)
31. Sanchez-Alavez M, Klein I, Brownell SE, Tabarean IV, Davis CN, Conti B, Bartfai T (2007) Night eating and obesity in the EP3Rdeficient mouse. Proc Natl Acad Sci U S A 104:3009-3014 (Pubitemid 46327994)
32. Miller CW, Casimir DA, Ntambi JM (1996) The mechanism of inhibition of 3T3-L1 preadipocyte differentiation by prostaglandin F2alpha. Endocrinology 137:5641-5650
33. Wang P, Renes J, Bouwman F, Bunschoten A, Mariman E, Keijer J (2007) Absence of an adipogenic effect of rosiglitazone on mature 3T3-L1 adipocytes: increase of lipid catabolism and reduction of adipokine expression. Diabetologia 50:654-665 (Pubitemid 46215510)
34. Dahlman I, Linder K, Arvidsson Nordstrom E, Andersson I, Liden J, Verdich C, Sorensen TI, Arner P (2005) Changes in adipose tissue gene expression with energy-restricted diets in obese women. Am J Clin Nutr 81:1275-1285 (Pubitemid 41710227)